Quest Diagnostics Incorporated Stock price
Equities
DGX
US74834L1008
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
133.1 USD | +1.56% | +3.32% | -3.46% |
Financials (USD)
Sales 2024 * | 9.4B | Sales 2025 * | 9.72B | Capitalization | 14.74B |
---|---|---|---|---|---|
Net income 2024 * | 886M | Net income 2025 * | 955M | EV / Sales 2024 * | 1.97 x |
Net Debt 2024 * | 3.77B | Net Debt 2025 * | 3.18B | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
15.7
x | Employees | 44,000 |
Yield 2024 * |
2.17% | Yield 2025 * |
2.24% | Free-Float | 67.87% |
Latest transcript on Quest Diagnostics Incorporated
1 day | +1.56% | ||
1 week | +3.32% | ||
Current month | +6.58% | ||
1 month | +5.93% | ||
3 months | -3.31% | ||
6 months | +7.91% | ||
Current year | -3.46% |
Managers | Title | Age | Since |
---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 13-03-31 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 22-07-10 |
Kristin Wallace
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 19-02-17 |
Timothy Ring
BRD | Director/Board Member | 67 | 11-12-06 |
Gail Wilensky
BRD | Director/Board Member | 80 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.84% | 227 M€ | +6.28% | - | |
2.17% | 2 M€ | +12.97% | ||
2.05% | 8 M€ | +6.91% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 133.1 | +1.56% | 888,001 |
24-03-27 | 131.1 | +1.70% | 753,019 |
24-03-26 | 128.9 | -0.32% | 666,194 |
24-03-25 | 129.3 | -0.02% | 584,237 |
24-03-22 | 129.3 | +0.36% | 708,135 |
Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.46% | 14.74B | |
+1.01% | 100B | |
+23.22% | 88.22B | |
+10.42% | 29.28B | |
-3.88% | 18.37B | |
+19.69% | 12.27B | |
+31.78% | 12.11B | |
+0.17% | 12.26B | |
-12.00% | 11.41B | |
-32.11% | 11.68B |